News Category
A new study published in Critical Care Medicine demonstrates that VolitionRx's Nu.Q NETs H3.1 biomarker independently predicts 28-day mortality and re...
A new scoring system combining biopsy and blood test trends identifies that only a small fraction of early liver rejection cases require treatment, po...
The Outstanding Photo Award's 41st season showcases winners from 14 countries, highlighting the importance of international recognition in family and ...
VolitionRx's new Capture-Seq technology achieves >99% pure ctDNA isolation, potentially transforming cancer detection and monitoring, with implication...
Aperam released its 2026 Half-Year Report, emphasizing its leadership in stainless and specialty steel and its dedication to sustainability through re...
VolitionRx announces increasing body of peer-reviewed studies supporting its Nu.Q H3.1 test as a biomarker for sepsis, showing ability to distinguish ...
Bill Humphreys' new book 'What If?' offers true stories from his unconventional life, inspiring readers to embrace risk and perseverance.
VolitionRx announced a collaboration with Sysmex to optimize its Nu.Q® NETs H3.1 assay on Sysmex's diagnostic platform, targeting a $3.8 billion marke...
VolitionRx has filed a strategic patent for using its Nu.Q technology to triage and monitor suspected Ebola patients, aiming to provide a low-cost bed...
VolitionRx provided a corporate update highlighting clinical and commercial progress, including a feline lymphoma manuscript submission tied to a pote...
VolitionRx's Nu.Q Vet Feline prototype assay demonstrates 97% specificity in detecting feline lymphoma, paving the way for a commercial liquid biopsy ...
KBC's launch of Ether and Bitcoin trading within its existing retail framework marks a significant move by European banks to integrate crypto into cor...
JD.com’s European expansion of its Joybuy platform directly challenges Amazon and Alibaba, signaling a new phase of global e-commerce rivalry.
VolitionRx reports a breakthrough in liquid biopsy technology that isolates circulating tumor-derived DNA with over 99% purity, enabling multi-cancer ...
VolitionRx provided an update on its clinical and commercial advancements, including a new cancer detection method estimated to address a $23 billion ...
First Orion announces the April 2026 release of its Global Exchange, adding CAMARA-standard API support and expanding international carrier connectivi...
The 4th edition of Jacqueline Tournier's book, which uses a three-animal metaphor to explain stress and brain function, is now available worldwide, ai...
VolitionRx announces a new method called Capture-Seq that achieves 180-fold enrichment of transcription factor–bound DNA fragments, potentially overco...
ParaZero Technologies highlights its DefendAir soft-capture drone defense system as Europe faces a surge in hostile drone activity, including airport ...
The event brings together over 260 exhibitors from 14 countries, highlighting Hong Kong's role as an east-meets-west design hub and featuring internat...
BluSky AI's innovative Neocloud platform and modular SkyMod technology aim to democratize AI infrastructure, addressing the industry's urgent need for...
